Insulet Corp (PODD) stock price, news and key stats
Price
Last close as of Sep 16, 2026. Delayed data; not a live quote.
- Previous close
- $139.24
- Open
- $138.86
- Day range
- $138.11 – $143.45
- Volume
- 1.3M
About Insulet Corp
Insulet Corporation is a medical device company, primarily exposed to the diabetes management market through its Omnipod insulin delivery system.
Latest PODD news
- Artisan Sold Insulet (PODD) Due to Competition ConcernsYahoo Finance · Sep 8, 2026
Artisan Partners has divested its stake in Insulet Corporation (PODD), citing growing concerns over competition and recent quality control issues. The decision comes on the heels of two significant recalls of Insulet's Omnipod devices, which have raised alarms among analysts regarding the company's manufacturing capabilities and overall product reliability. These recalls have not only affected consumer confidence but have also led to increased scrutiny from investors about Insulet's ability to maintain its competitive edge in the rapidly evolving diabetes management market. The implications for Insulet are significant, as the recalls may hinder its market share growth and tarnish its reputation among healthcare providers and patients alike. With competitors ramping up their offerings in the continuous glucose monitoring and insulin delivery space, Insulet faces pressure to address these quality concerns swiftly. The market reaction to Artisan's decision could further exacerbate volatility in Insulet's stock, as investors reassess the company's long-term prospects amidst these challenges. As competition intensifies, the focus will be on how Insulet manages its manufacturing processes and restores confidence among stakeholders.
Index membership
- S&P 500 · Health Care
Related Health Care stocks
Chart, AI research and agents for PODD
Open PODD in Watchgar for the live chart, AI-graded news, insider and institutional flow, and automated trading agents. Free to start, no card required.
Open PODD in Watchgar